查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1769594

显微外科及超显微外科的全球市场:各终端用户，设备，手术，各地区 - 2032年前的预测分析

Global Microsurgery & Super-Microsurgery Market Research by End User, by Equipment, by Procedure, by Region Forecast Analysis till 2032
出版日期: | 出版商: Market Research Future | 英文 148 Pages | 订单完成后即时交付

价格

产业概要

2022 年，显微外科和超显微外科市场规模为 19.6154 亿美元。预计到 2032 年，该市场规模将达到 37.8366 亿美元，2023 年至 2032 年的复合年增长率为 6.07%。

人口老化和外科手术数量的增加是全球显微外科和超显微外科市场的主要驱动力。研发创新和移植手术的激增推动了对精准手术方法的需求，尤其是在骨科和重建领域。慢性疾病和与年龄相关的健康问题进一步加速了对高成功率显微外科技术的需求。

然而，市场面临着许多障碍，例如手术併发症，包括感染、伤口癒合延迟、神经损伤、可见疤痕、麻醉相关问题以及再次手术的需求。

积极的一面是，由于生活方式相关疾病的增加和技术的不断进步，市场提供了巨大的机会。由于政府的批准以及先进眼科显微镜等新工具的开发，手术精度正在提高。随着老年人和年轻人口中生活方式相关疾病的增多，这些技术创新可能会透过提供更安全、更有效的显微手术选择来推动市场成长。

产业区隔

全球显微手术和超显微手术市场按最终用户（例如医院和门诊手术中心）进行细分。

依设备类型，全球显微外科和超显微外科市场分为手术显微镜、超微型缝合线、超微型钳、显微外科持针器、手术刀/眼科手术刀及其他。

依手术类别，全球显微外科及超显微外科市场细分为骨科显微外科、眼科显微外科、整形及重建显微外科、耳鼻喉科显微外科、神经科显微外科及妇科及泌尿科显微外科。

区域分析

全球显微外科和超显微外科市场持续发展，各地区呈现不同的趋势。北美市场实现了显着成长，主要得益于医疗技术的快速进步以及各专业领域对微创手术技术的日益青睐。

在欧洲，受医疗创新浪潮、人口老化和慢性病增加的推动，市场已显着成熟。使用精密仪器和显微镜的显微外科技术，以及高度专业化的超显微外科技术，如今已广泛应用于重建外科、骨科、眼科和整形外科。

在积极的研发投入推动下，亚太地区发展势头强劲。领先的医疗中心和大学正走在改进和开发复杂外科技术的前沿，以提高精准度和治疗效果。

相较之下，中东、非洲和拉丁美洲的市场正在扩张，但仍面临课题。这些地区正在意识到先进显微外科技术的潜力，但由于缺乏熟练的专业人员、昂贵的医疗设备以及医疗基础设施的缺口，进展缓慢。儘管人们对这些先进技术的兴趣日益浓厚，但这些课题限制了其可近性，并阻碍了其广泛应用。

主要参与者

奥林巴斯公司 (Olympus Corporation)、控制公司 (Kontron AG)、B.Braun SE、捷迈邦美 (Zimmer Biomet)、卡尔蔡司医疗 (Carl Zeiss Meditec)、全球外科公司 (Global Surgical Corporation)、Karl Kaps GmbH &Co.KG、美敦力 (Medtronic)、拓朴AB、史赛克 (Stryker)、BVI、强生服务公司 (Johnson &Johnson Services Inc)、Haag-Streit 集团、KLS 马丁集团 (KLS Martin Group)、Microsurgery Instruments Inc、Peter Lazic GmbH、Alco Inc、Synovis Micro Companies Alliance Inc. 等是全球超显微外科和主要产业的主要参与者。

目录

第1章 摘要整理

第2章 市场简介

第3章 调查手法

  • 概要
  • 资料流程
  • 购买的资料库：
  • 二手资料来源
  • 一手资料研究
  • 市场规模估算方法
  • 资料预测
  • 资料最终用户
  • 团队与分析师贡献

第4章 市场动态

  • 简介
  • 促进因素
    • 外科手术增加
    • 老化加剧人口
  • 阻碍因素
    • 不同手术的併发症与风险
  • 机遇
    • 生活方式相关疾病的增加与技术进步

第5章 市场要素分析

  • 价值链分析
    • 研究开发
    • 製造
    • 流通与销售
    • 销售后监测
  • 波特的五力分析
  • COVID-19对全球显微外科及超显微外科市场带来的影响
    • 供应链的影响
    • 主要加入企业的影响
    • 需求与供给的影响

第6章 全球显微外科及超显微外科市场(设备)

  • 概要
  • 手术用显微镜
  • 超级微缝合线
  • 微钳子
  • 微爵士果冻针保持者
  • 外科用手术刀/眼科用小刀
  • 其他

第7章 全球显微外科及超显微外科市场(手术)

  • 概要
  • 整形外科微爵士果冻
  • 眼科微爵士果冻
  • 整形外科及重组微爵士果冻
  • 耳鼻喉科微爵士果冻
  • 神经学的微小外科手术
  • 妇产科及泌尿科微爵士果冻
  • 其他

第8章 全球显微外科及超显微外科市场(各终端用户)

  • 概要
  • 医院
  • 门诊病人手术中心
  • 其他

第9章 全球显微外科及超显微外科市场(各地区)

  • 概要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他
  • 其他地区
    • 中东
    • 南美

第10章 竞争情形

  • 简介
  • 2022年的市场占有率分析
  • 竞争仪表板
  • 公共播放器的股票摘要
  • 比较分析:主要加入企业的财务
  • 主要的发展与成长策略
    • 产品的销售/产品核可

第1章 收购/投资/扩张

  • 竞争产品分析
    • 手术用显微镜
    • 微钳子
    • 超级微缝合线
    • 微爵士果冻针保持者
    • 外科用手术刀/眼科用小刀

第11章 企业简介

  • KONTRON AG
  • CARL ZEISS MEDITEC AG
  • GLOBAL SURGICAL CORPORATION
  • KARL KAPS GMBH & CO. KG
  • MEDTRONIC
  • OLYMPUS CORPORATION
  • SMITH+NEPHEW
  • ZIMMER BIOMET
  • TOPCON CORPORATION
  • STILLE AB

第1章 主要策略

  • B. BRAUN SE
  • STRYKER
  • BVI
  • JOHNSON & JOHNSON SERVICES INC
  • HAAG-STREIT GROUP
  • KLS MARTIN GROUP
  • 显微外科 INSTRUMENTS, INC
  • PETER LAZIC GMBH
  • ALCON INC
  • SYNOVIS MICRO COMPANIES ALLIANCE, INC

第12章 资料的引用

Product Code: MRFR/HC/19909-CR

Global Microsurgery & Super-Microsurgery Market Research by End User (Hospitals, Ambulatory Surgical Centers, Others), by Equipment (Operating Microscopes, Super Micro Sutures, Micro Forceps, Microsurgery Needle Holder, Surgical Scalpel/ Ophthalmic Knives, Others), by Procedure (Orthopedic Microsurgery, Ophthalmic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Gynecological & Urological Microsurgery, Others), by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast Analysis till 2032

Industry Overview

The market for microsurgery and super-microsurgery was valued at USD 1,961.54 million in 2022 and is expected to reach USD 3,783.66 million in 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.07% between 2023 and 2032.

The aging population and the rise in surgical operations are the main drivers of global microsurgery and super-microsurgery market. Innovations in research and development, along with a surge in transplant operations, have increased the demand for precise surgical methods, particularly in orthopedic and reconstructive fields. Chronic illnesses and age-related health issues further accelerate the need for high-success microsurgical techniques.

However, the market encounters barriers such as surgical complications, including infections, delayed wound healing, nerve damage, visible scarring, anesthesia-related problems, and the possible requirement for follow-up surgeries.

On the positive side, the market presents substantial opportunities due to the rise in lifestyle-related disorders and continued technological improvements. Government approvals and the development of new tools like advanced ophthalmic microscopes are enhancing procedural accuracy. As lifestyle diseases increase among both older and younger demographics, these innovations will drive market growth by offering safer, more effective microsurgical options.

Industry Segmentations

Global microsurgery and super microsurgery market is segmented by the end user, includes hospitals and ambulatory surgical centers and others.

In terms of equipment type, global microsurgery and super microsurgery market is categorized into operating microscopes, super micro sutures, micro forceps, microsurgery needle holder, surgical scalpel/ ophthalmic knives, and others.

Based on the procedure category, global microsurgery and super microsurgery market has been segmented into Orthopedic Microsurgery, Ophthalmic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Gynecological & Urological Microsurgery.

North America, Asia Pacific, Europe, and rest of the world are the part of regional types of global market.

Regional Analysis

Global microsurgery and super-microsurgery market continues to evolve with distinct trends across regions. North America has experienced substantial growth, largely due to rapid advancements in medical technology and a growing inclination toward minimally invasive surgical techniques used in various specialties.

In Europe, the market has matured significantly, supported by a surge in medical innovations, an aging population, and a rise in chronic illnesses. Microsurgical techniques involving precision tools and microscopes, along with highly specialized super-microsurgery methods, are now widely utilized in reconstructive surgery, orthopedics, ophthalmology, and plastic surgery.

The Asia Pacific region is showing impressive momentum, spurred by active investment in research and development. Top-tier medical centers and universities are at the cutting edge of refining and developing complex surgical procedures that enhance accuracy and treatment outcomes.

In contrast, the market in the Middle East, Africa, and Latin America is expanding but still faces hurdles. Although these regions are recognizing the potential of advanced microsurgical techniques, progress is slowed by the lack of skilled professionals, expensive medical equipment, and gaps in healthcare infrastructure. These challenges limit accessibility and prevent widespread adoption, even as interest in these advanced procedures grows steadily.

Key Players

Olympus Corporation, Kontron AG, B. Braun SE, Zimmer Biomet, Carl Zeiss Meditec, Global Surgical Corporation, Karl Kaps GmbH & Co. KG, Medtronic, Smith+Nephew, Topcon Corporation, Stille AB, Stryker, BVI, Johnson & Johnson Services Inc, Haag-Streit Group, KLS Martin Group, Microsurgery Instruments Inc, Peter Lazic GmbH, Alco Inc, Synovis Micro Companies Alliance Inc. are the key companies of global microsurgery and super microsurgery industry.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
    • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TECHNIQUE
  • 3.8 DATA END USERLING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA END USERLING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 GROWING NUMBER OF SURGICAL PROCEDURES
    • 4.2.2 INCREASING NUMBER OF GERIATRIC POPULATION
  • 4.3 RESTRAINTS
    • 4.3.1 COMPLICATIONS AND RISKS DUE TO THE PROCEDURE
  • 4.4 OPPORTUNITY
    • 4.4.1 INCREASING INCIDENCE OF LIFESTYLE DISORDERS AND GROWING TECHNOLOGICAL ADVANCEMENTS

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION AND SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET
    • 5.3.1 IMPACT ON SUPPLY CHAIN
    • 5.3.2 IMPACT ON KEY PLAYERS
    • 5.3.3 IMPACT ON DEMAND AND SUPPLY

6 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT

  • 6.1 OVERVIEW
  • 6.2 OPERATING MICROSCOPES
  • 6.3 SUPER MICRO SUTURES
  • 6.4 MICRO FORCEPS
  • 6.5 MICROSURGERY NEEDLE HOLDER
  • 6.6 SURGICAL SCALPEL/ OPHTHALMIC KNIVES
  • 6.7 OTHERS

7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE

  • 7.1 OVERVIEW
  • 7.2 ORTHOPEDIC MICROSURGERY
  • 7.3 OPHTHALMIC MICROSURGERY
  • 7.4 PLASTIC & RECONSTRUCTIVE MICROSURGERY
  • 7.5 ENT MICROSURGERY
  • 7.6 NEUROLOGICAL MICROSURGERY
  • 7.7 GYNECOLOGICAL & UROLOGICAL MICROSURGERY
  • 7.8 OTHERS

8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS
  • 8.3 AMBULATORY SURGICAL CENTERS
  • 8.4 OTHERS

9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 FRANCE
    • 9.3.3 UK
    • 9.3.4 ITALY
    • 9.3.5 SPAIN
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA-PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 JAPAN
    • 9.4.3 INDIA
    • 9.4.4 AUSTRALIA
    • 9.4.5 SOUTH KOREA
    • 9.4.6 REST OF ASIA-PACIFIC
  • 9.5 REST OF WORLD
    • 9.5.1 MIDDLE EAST
    • 9.5.2 SOUTH AMERICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 MARKET SHARE ANALYSIS, 2022
  • 10.3 COMPETITOR DASHBOARD
  • 10.4 PUBLIC PLAYERS STOCK SUMMARY
  • 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

1 0.6.2 ACQUISITION/INVESTMENT/EXPANSION

  • 10.7 COMPETITOR PRODUCT ANALYSIS
    • 10.7.1 OPERATING MICROSCOPES
    • 10.7.2 MICRO FORCEPS
    • 10.7.3 SUPER MICRO SUTURES
    • 10.7.4 MICROSURGERY NEEDLE HOLDER
    • 10.7.5 SURGICAL SCALPEL/ OPHTHALMIC KNIVES

11 COMPANY PROFILES

  • 11.1 KONTRON AG
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 KEY STRATEGIES
  • 11.2 CARL ZEISS MEDITEC AG
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 GLOBAL SURGICAL CORPORATION
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 KEY STRATEGIES
  • 11.4 KARL KAPS GMBH & CO. KG
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 KEY STRATEGIES
  • 11.5 MEDTRONIC
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 SWOT ANALYSIS
    • 11.5.6 KEY STRATEGIES
  • 11.6 OLYMPUS CORPORATION
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 KEY STRATEGIES
  • 11.7 SMITH+NEPHEW
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 KEY STRATEGIES
  • 11.8 ZIMMER BIOMET
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 TOPCON CORPORATION
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 KEY STRATEGIES
  • 11.10 STILLE AB
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS

1 1.10.5 KEY STRATEGIES

  • 11.11 B. BRAUN SE
    • 11.11.1 COMPANY OVERVIEW
    • 11.11.2 FINANCIAL OVERVIEW
    • 11.11.3 PRODUCT OFFERED
    • 11.11.4 KEY DEVELOPMENTS
    • 11.11.5 SWOT ANALYSIS
    • 11.11.6 KEY STRATEGY
  • 11.12 STRYKER
    • 11.12.1 COMPANY OVERVIEW
    • 11.12.2 FINANCIAL OVERVIEW
    • 11.12.3 PRODUCTS OFFERED
    • 11.12.4 KEY DEVELOPMENTS
    • 11.12.5 KEY STRATEGIES
  • 11.13 BVI
    • 11.13.1 COMPANY OVERVIEW
    • 11.13.2 FINANCIAL OVERVIEW
    • 11.13.3 PRODUCTS OFFERED
    • 11.13.4 KEY DEVELOPMENTS
    • 11.13.5 KEY STRATEGY
  • 11.14 JOHNSON & JOHNSON SERVICES INC
    • 11.14.1 COMPANY OVERVIEW
    • 11.14.2 FINANCIAL OVERVIEW
    • 11.14.3 PRODUCTS OFFERED
    • 11.14.4 KEY DEVELOPMENTS
    • 11.14.5 SWOT ANALYSIS
    • 11.14.6 KEY STRATEGIES
  • 11.15 HAAG-STREIT GROUP
    • 11.15.1 COMPANY OVERVIEW
    • 11.15.2 FINANCIAL OVERVIEW
    • 11.15.3 PRODUCTSOFFERED
    • 11.15.4 KEY DEVELOPMENTS
    • 11.15.5 KEY STRATEGIES
  • 11.16 KLS MARTIN GROUP
    • 11.16.1 COMPANY OVERVIEW
    • 11.16.2 FINANCIAL OVERVIEW
    • 11.16.3 PRODUCT OFFERED
    • 11.16.4 KEY DEVELOPMENTS
    • 11.16.5 KEY STRATEGIES
  • 11.17 MICROSURGERY INSTRUMENTS, INC
    • 11.17.1 COMPANY OVERVIEW
    • 11.17.2 FINANCIAL OVERVIEW
    • 11.17.3 PRODUCTS OFFERED
    • 11.17.4 KEY DEVELOPMENTS
    • 11.17.5 KEY STRATEGIES
  • 11.18 PETER LAZIC GMBH
    • 11.18.1 COMPANY OVERVIEW
    • 11.18.2 FINANCIAL OVERVIEW
    • 11.18.3 PRODUCT OFFERED
    • 11.18.4 KEY DEVELOPMENTS
    • 11.18.5 KEY STRATEGIES
  • 11.19 ALCON INC
    • 11.19.1 COMPANY OVERVIEW
    • 11.19.2 FINANCIAL OVERVIEW
    • 11.19.3 PRODUCT OFFERED
    • 11.19.4 KEY DEVELOPMENTS
    • 11.19.5 KEY STRATEGIES
  • 11.20 SYNOVIS MICRO COMPANIES ALLIANCE, INC
    • 11.20.1 COMPANY OVERVIEW
    • 11.20.2 FINANCIAL OVERVIEW
    • 11.20.3 PRODUCT OFFERED
    • 11.20.4 KEY DEVELOPMENTS
    • 11.20.5 KEY STRATEGIES

12 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD END USERLING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 3 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR TOPERATING MICROSCOPES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 4 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR SUPER MICRO SUTURES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR MICRO FORCEPS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 6 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR MICROSURGERY NEEDLE HOLDER, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR SURGICAL SCALPEL/ OPHTHALMIC KNIVES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 10 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR ORTHOPEDIC MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 11 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OPHTHALMIC MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 12 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR PLASTIC & RECONSTRUCTIVE MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR ENT MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 14 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR NEUROLOGICAL MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 15 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR GYNECOLOGICAL & UROLOGICAL MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 16 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 18 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR HOSPITALS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 19 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 20 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 21 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 22 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 23 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 24 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 25 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 26 US: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 27 US: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 28 US: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 29 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 30 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 31 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 32 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 33 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 34 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 35 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 36 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 37 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 38 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 39 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 40 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 41 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 42 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 43 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 44 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 45 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 46 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 47 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 48 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 49 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 50 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 51 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 52 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 53 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 54 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 56 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 57 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 59 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 60 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 62 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 63 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 65 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 66 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 68 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 69 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 71 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 72 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 74 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 75 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 78 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 79 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 81 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 82 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 84 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 85 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 87 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • TABLE 88 PRODUCT LAUNCH/PRODUCT APPROVAL
  • TABLE 89 ACQUISITION /INVESTMENT/EXPANSION/COLLABORATION
  • TABLE 90 KONTRON AG: PRODUCTS OFFERED
  • TABLE 91 CARL ZEISS MEDITEC AG: PRODUCTS OFFERED
  • TABLE 92 CARL ZEISS MEDITEC AG: KEY DEVELOPMENTS
  • TABLE 93 GLOBAL SURGICAL CORPORATION: PRODCUTS OFFERED
  • TABLE 94 KARL KAPS GMBH & CO. KG: PRODCUTS OFFERED
  • TABLE 95 MEDTRONIC: PRODCUTS OFFERED
  • TABLE 96 OLYMPUS CORPORATION: PRODCUTS OFFERED
  • TABLE 97 SMITH+NEPHEW: PRODCUTS OFFERED
  • TABLE 98 ZIMMER BIOMET: PRODCUTS OFFERED
  • TABLE 99 TOPCON CORPORATION: PRODCUTS OFFERED
  • TABLE 100 STILLE AB: PRODCUTS OFFERED
  • TABLE 101 STILLE AB: KEY DEVELOPMENTS
  • TABLE 102 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 103 STRYKER: PRODCUTS OFFERED
  • TABLE 104 BVI: PRODCUTS OFFERED
  • TABLE 105 BVI: KEY DEVELOPMENTS
  • TABLE 106 JOHNSON & JOHNSON SERVICES INC: PRODUCTS OFFERED
  • TABLE 107 HAAG-STREIT GROUP: PRODUCTS OFFERED
  • TABLE 108 KLS MARTIN GROUP: PRODUCTSOFFERED
  • TABLE 109 MICROSURGERY INSTRUMENTS, INC: PRODUCTS OFFERED
  • TABLE 110 PETER LAZIC GMBH: PRODUCT OFFERED
  • TABLE 111 ALCON: PRODUCT OFFERED
  • TABLE 112 SYNOVIS MICRO COMPANIES ALLIANCE, INC: PRODUCT OFFERED
  • TABLE 113 SYNOVIS MICRO COMPANIES ALLIANCE, INC: KEY DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET: STRUCTURE
  • FIGURE 2 GLOBAL MICROSURGERY AND SUPER-MICROSURGERY MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
  • FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET
  • FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET
  • FIGURE 7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, EQUIPMENT SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)
  • FIGURE 8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2022 & 2032(USD MILLION)
  • FIGURE 9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY EQUIPMENT, 2022 (%)
  • FIGURE 10 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, PROCEDURE SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)
  • FIGURE 11 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2022 & 2032(USD MILLION)
  • FIGURE 12 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY PROCEDURE, 2022 (%)
  • FIGURE 13 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, END USER SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)
  • FIGURE 14 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2022 & 2032(USD MILLION)
  • FIGURE 15 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY END USER, 2022 (%)
  • FIGURE 16 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION, 2022 & 2032 (USD MILLION)
  • FIGURE 17 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY REGION, 2022
  • FIGURE 18 NORTH AMERICA MARKET ANALYSIS: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION)
  • FIGURE 19 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)
  • FIGURE 20 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 21 EUROPE MARKET ANALYSIS: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION)
  • FIGURE 22 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)
  • FIGURE 23 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 24 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION)
  • FIGURE 25 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 (% SHARE)
  • FIGURE 26 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 & 2032 (USD MILLION)
  • FIGURE 27 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION)
  • FIGURE 28 REST OF WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 (% SHARE)
  • FIGURE 29 REST OF WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2021 & 2030 (USD MILLION)
  • FIGURE 30 GLOBAL MICROSURGERY & SUPER-MICROSURGERY PLAYERS: COMPETITIVE ANALSIS, 2022
  • FIGURE 31 COMPETITOR DASHBOARD: GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET
  • FIGURE 32 COMPETITORS PRODUCT ANALYSIS: OPERATING MICROSCOPES
  • FIGURE 33 COMPETITORS PRODUCT ANALYSIS: MICRO FORCEPS
  • FIGURE 34 COMPETITORS PRODUCT ANALYSIS: SUPER MICRO SUTURES
  • FIGURE 35 COMPETITORS PRODUCT ANALYSIS: MICROSURGERY NEEDLE HOLDER
  • FIGURE 36 COMPETITORS PRODUCT ANALYSIS: SURGICAL SCALPEL/ OPHTHALMIC KNIVES
  • FIGURE 37 KONTRON AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 38 CARL ZEISS MEDITEC AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 39 CARL ZEISS MEDITEC AG: SWOT ANALYSIS
  • FIGURE 40 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 41 MEDTRONIC: SWOT ANALYSIS
  • FIGURE 42 OLYMPUS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 43 SMITH+NEPHEW: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 44 ZIMMER BIOMET: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 45 ZIMMER BIOMET: SWOT ANALYSIS
  • FIGURE 46 TOPCON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 47 STILLE AB: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 48 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 49 B. BRAUN SE: SWOT ANALYSIS
  • FIGURE 50 STRYKER: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 51 JOHNSON & JOHNSON SERVICES INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 52 JOHNSON & JOHNSON SERVICES INC: SWOT ANALYSIS
  • FIGURE 53 ALCON INC: FINANCIAL OVERVIEW SNAPSHOT